Disclosed are compounds which inhibit SSAO enzyme activity. Also disclosed are pharmaceutical compositions comprising these compounds and the use of these compounds in the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases, immune disorders and the inhibition of tumor growth.
本发明涉及抑制S
SAO酶活性的化合物。还涉及包含这些化合物的制药组合物以及在治疗或预防抑制S
SAO活性有益的医疗状况中使用这些化合物,例如炎症性疾病,免疫障碍和抑制肿瘤生长。